ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) Debt / Equity
- 2022-09-30: Debt/Equity Ratio 0.41.
- 2022-06-30: Debt/Equity Ratio 0.37.
- 2022-03-31: Debt/Equity Ratio 0.34.
- 2021-12-31: Debt/Equity Ratio 0.28.
Complete source-backed debt/equity ratio history.
- Available history
- 2020-12-31 to 2022-09-30
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2022-09-30 | 0.41 |
| 2022-06-30 | 0.37 |
| 2022-03-31 | 0.34 |
| 2021-12-31 | 0.28 |
| 2021-09-30 | 0.23 |
| 2021-06-30 | 0.2 |
| 2021-03-31 | 0.17 |
| 2020-12-31 | 0.04 |
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2021-12-31 | 0.28 |
| 2020-12-31 | 0.04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |